Reykjavik, Iceland/Copenhagen, Denmark, 23 December 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the completion of the share buyback program, which was announced in Company Announcement no. 3/2025 dated 7 February 2025. Following are the last transactions carried out under the current share buyback program.
The purpose of the Program was to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Capital Allocation Policy. Embla Medical could acquire 2,000,000 shares under the Program for total consideration not exceeding USD 10 million up until and including December 31, 2025.
Embla Medical acquired 1,987,027 shares under the Program at an average price of DKK 32.00. Following the last transactions, Embla Medical currently holds 2,673,596 shares, corresponding to 0.62% of the Company’s total share capital.
The Program on Nasdaq Copenhagen was carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (“MAR”), and the Commission’s delegated regulation 2016/1052.
If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors
About Embla Medical
Read more on News Powered by Cision
